FINVX | LIRRX | FINVX / LIRRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 16 years | - |
Gain YTD | 8.781 | 8.582 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.9B | 394M | 3,782% |
Annual Yield % from dividends | 3.05 | 2.82 | 108% |
Returns for 1 year | 11.83 | 11.32 | 104% |
Returns for 3 years | 25.17 | 10.79 | 233% |
Returns for 5 years | 48.73 | 18.44 | 264% |
Returns for 10 years | 60.24 | 18.89 | 319% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BHSRX | 61.42 | N/A | N/A |
BlackRock Health Sciences Opps R | |||
GVIZX | 12.00 | N/A | N/A |
GuideStone Funds Value Equity Index Inv | |||
FCGYX | 19.70 | -0.07 | -0.35% |
NYLI PineStone Global Equity Class C | |||
BCSAX | 8.26 | -0.06 | -0.72% |
BlackRock Commodity Strategies Inv A | |||
PMDDX | 18.91 | -0.23 | -1.20% |
Principal Small-MidCap Dividend Inc C |